Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

27.12
-0.7900-2.83%
Post-market: 26.93-0.1900-0.70%19:55 EST
Volume:318.33K
Turnover:8.70M
Market Cap:806.31M
PE:-32.54
High:27.80
Open:27.23
Low:27.07
Close:27.91
52wk High:44.28
52wk Low:14.59
Shares:29.73M
Float Shares:25.11M
Volume Ratio:0.48
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8334
EPS(LYR):-0.8334
ROE:-5.21%
ROA:-2.56%
PB:1.71
PE(LYR):-32.54

Loading ...

Castle Biosciences CEO Derek J. Maetzold Reports Disposal of Common Shares

Reuters
·
Nov 27, 2025

Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Reports Disposal of Common Shares

Reuters
·
Nov 25, 2025

Castle Biosciences (CSTL): Evaluating Valuation After New Data on DecisionDx-Melanoma Diagnostic Advances

Simply Wall St.
·
Nov 22, 2025

Scibase And Castle Biosciences Expand Collaboration

Reuters
·
Nov 20, 2025

Castle Biosciences Unveils New Data Showing DecisionDx-Melanoma Improves Sentinel Lymph Node Biopsy Decision Making

Reuters
·
Nov 14, 2025

New Data Confirms Performance of Decisiondx®-Melanoma to Identify Patients With Less Than Five Percent Risk of Sentinel Lymph Node Positivity

THOMSON REUTERS
·
Nov 14, 2025

Castle Biosciences CFO Frank Stokes Reports Disposal of Common Shares

Reuters
·
Nov 14, 2025

Kristen M. Oelschlager, Chief Operating Officer, Reports Disposal of Castle Biosciences Inc. Common Shares

Reuters
·
Nov 14, 2025

Castle Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference

Reuters
·
Nov 11, 2025

SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million

Reuters
·
Nov 07, 2025

Scibase and Castle Biosciences Expand Collaboration and License Agreement and Enter Into Loan Agreement of SEK 20 Million

THOMSON REUTERS
·
Nov 07, 2025

Scibase And Castle Biosciences Expand Collaboration

Reuters
·
Nov 07, 2025

SciBase Secures SEK 20 Million Loan from Castle Biosciences

Reuters
·
Nov 07, 2025

Stock Track | Castle Biosciences Soars 5.03% as BTIG Maintains Buy Rating

Stock Track
·
Nov 06, 2025

Castle Biosciences Navigates Regulatory Uncertainty Amid Shifting Policies and Trade Challenges

TIPRANKS
·
Nov 05, 2025

Castle Biosciences COO Kristen M. Oelschlager Reports Disposal of Common Shares

Reuters
·
Nov 05, 2025

Castle Biosciences Is Maintained at Outperform by Baird

Dow Jones
·
Nov 05, 2025

Stock Track | Castle Biosciences Soars 6% as Leerink Partners Boosts Price Target

Stock Track
·
Nov 04, 2025

U.S. RESEARCH ROUNDUP-Affiliated Managers Group, Argenx, Cardinal Health

Reuters
·
Nov 04, 2025

Castle Biosciences Inc : Leerink Partners Raises Target Price to $40 From $35

THOMSON REUTERS
·
Nov 04, 2025